Travere Therapeutics
TVTX
TVTX
119 hedge funds and large institutions have $908M invested in Travere Therapeutics in 2018 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0.24% more ownership
Funds ownership: 102.02% → 102.26% (+0.24%)
1% less funds holding
Funds holding: 120 → 119 (-1)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
119
Holding in Top 10
2
Calls
$8.85M
Puts
$1.21M
Top Buyers
| 1 | +$15.4M | |
| 2 | +$12.1M | |
| 3 | +$11M | |
| 4 |
Millennium Management
New York
|
+$8.47M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$7.03M |
Top Sellers
| 1 | -$18.6M | |
| 2 | -$10.9M | |
| 3 | -$10.4M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$6.37M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$6.03M |